Evidence map›Paper›PMID 38269052›Full record

ArticleOpen forum infectious diseases2024

Clinical Outcomes of US Adults Hospitalized for COVID-19 and Influenza in the Respiratory Virus Hospitalization Surveillance Network, October 2021-September 2022.

Noah Kojima, Christopher A Taylor, Mark W Tenforde, Dawud Ujamaa, Alissa O'Halloran, Kadam Patel, Shua J Chai, Pam Daily Kirley, Nisha B Alden, Breanna Kawasaki and 25 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Open forum infectious diseases, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 14 citations in OpenAlex.

  1. Comprehensive Analysis of Cardiovascular Events and Risk Factors in Patients Hospitalized With Respiratory Syncytial Virus.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

35 authors at 13 institutions in 1 country.

Noah KojimaInfluenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.ORCID https://orcid.org/0000-0002-3667-9719
Christopher A TaylorCoronavirus and Other Respiratory Viruses Division, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.ORCID https://orcid.org/0000-0002-0937-5461
Mark W TenfordeInfluenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Dawud UjamaaInfluenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Alissa O'HalloranInfluenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Kadam PatelCoronavirus and Other Respiratory Viruses Division, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Shua J ChaiCalifornia Emerging Infections Program, Oakland, California, USA.
Pam Daily KirleyCenters for Disease Control and Prevention, Atlanta, Georgia, USA.
Nisha B AldenColorado Department of Public Health and Environment, Denver, Colorado, USA.
Breanna KawasakiColorado Department of Public Health and Environment, Denver, Colorado, USA.
James MeekConnecticut Emerging Infections Program, New Haven, Connecticut, USA.
Kimberly Yousey-HindesConnecticut Emerging Infections Program, New Haven, Connecticut, USA.
Evan J AndersonSchool of Medicine, Emory University, Atlanta, Georgia, USA.
Kyle P OpenoSchool of Medicine, Emory University, Atlanta, Georgia, USA.
Libby ReegMichigan Department of Health and Human Services, Lansing, Michigan, USA.
Val Tellez NunezMichigan Department of Health and Human Services, Lansing, Michigan, USA.
Ruth LynfieldMinnesota Department of Health, Saint Paul, Minnesota, USA.
Kathryn Como-SabettiMinnesota Department of Health, Saint Paul, Minnesota, USA.
Susan L RoppNew Mexico Department of Health, Albuquerque, New Mexico, USA.
Yomei P ShawNew Mexico Department of Health, Albuquerque, New Mexico, USA.
Nancy L SpinaNew York State Department of Health, Albany, New York, USA.
Grant BarneyNew York State Department of Health, Albany, New York, USA.
Sophrena BusheySchool of Medicine and Dentistry, University of Rochester, Rochester, New York, USA.
Kevin PophamSchool of Medicine and Dentistry, University of Rochester, Rochester, New York, USA.
Nancy E MoranOhio Department of Health, Columbus, Ohio, USA.
Eli ShiltzOhio Department of Health, Columbus, Ohio, USA.
Melissa SuttonPublic Health Division, Oregon Health Authority, Portland, Oregon, USA.
Nasreen AbdullahPublic Health Division, Oregon Health Authority, Portland, Oregon, USA.
H Keipp TalbotVanderbilt University Medical Center, Nashville, Tennessee, USA.
William SchaffnerVanderbilt University Medical Center, Nashville, Tennessee, USA.
Ryan ChatelainSalt Lake County Health Department, Salt Lake City, Utah, USA.
Andrea PriceSalt Lake County Health Department, Salt Lake City, Utah, USA.
Shikha GargInfluenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.ORCID https://orcid.org/0000-0002-9345-6669
Fiona P HaversCoronavirus and Other Respiratory Viruses Division, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Catherine H BozioInfluenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Centers for Disease Control and Prevention · USColorado Department of Public Health and Environment · USEmory University · USLake County · USMichigan Department of Health and Human Services · USMinnesota Department of Health · USNew Mexico Department of Health · USNew York State Department of Health · USOhio Department of Health · USOregon Health Authority · USUniversity of Rochester · USVanderbilt University Medical Center · USYale University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Severe outcomes were common among adults hospitalized for COVID-19 or influenza, while the percentage of COVID-19 hospitalizations involving critical care decreased from October 2021 to September 2022. During the Omicron BA.5 period, intensive care unit admission frequency was similar for COVID-19 and influenza, although patients with COVID-19 had a higher frequency of in-hospital death.

Indexed as

COVID-19hospital outcomesinfluenzaSARS-CoV-2severe disease

Identifiers

PMID38269052
PMCPMC10807992
OpenAlexW4390450980

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.